Dr. Tracy M. Liang’s AI Braces map treatment before the first tooth moves

SMILE-FX Orthodontic Studio in Miramar, South Florida, has launched AI Braces, a proprietary orthodontic approach that combines artificial intelligence with high-resolution 3D CBCT imaging. According to the original report from Robotics & Automation News, the system is being introduced by board-certified orthodontist Dr. Tracy M. Liang to create more fully mapped treatment plans before braces treatment begins.

The useful part of the story is not that AI suddenly replaces the orthodontist. The more concrete shift is operational: the studio is trying to combine volumetric data from dental cone-beam CT imaging with algorithmic analysis so treatment planning relies less on static images, impressions, and manual judgment alone. CBCT can show teeth, roots, and surrounding structures in three dimensions, giving clinicians a more spatial view than conventional two-dimensional imaging.

In the best version of this workflow, such a system could help the clinician identify trouble spots before treatment begins: how teeth may move, where anatomy may limit the plan, how realistic an alignment target is, and where additional caution is needed. This is a practical form of medical AI: less dramatic than a hospital-scale diagnostic platform, but potentially useful inside a specialist clinic if the predictions are properly validated.

The available description, however, leaves the important questions unanswered. It does not say what data the system was trained on, how prediction accuracy is checked, whether there are comparisons with conventional planning, or whether AI Braces is a software layer, an internal protocol, or a bundle of multiple tools. In medicine, that distinction matters. The FDA already maintains a dedicated discussion around AI and machine-learning medical software because algorithmic recommendations in healthcare need clear limits, accountability, and evidence.

For patients, the practical question is straightforward: does AI Braces produce a better plan, shorter treatment, fewer revisions, or clearer communication about expected outcomes. From the published material, the defensible conclusion is narrower: SMILE-FX is introducing a more data-rich planning workflow at its Miramar practice. That is relevant for the South Florida market and for the broader digitization of orthodontics, but it is not yet evidence of a large clinical breakthrough.

Orthodontics remains a field where technology is only as useful as the professional judgment around it. The role of an orthodontist still includes diagnosis, risk assessment, biomechanics, and realistic patient expectations. AI Braces should therefore be read as a planning tool, not an autonomous clinician. If SMILE-FX later publishes validation results, case comparisons, or a clearer technical methodology, the story becomes much more consequential. For now, it is a useful example of AI moving from large medical systems into specialist practices, with the same old rule still intact: a prediction is only as strong as the evidence behind it.